1246 ET - Procter & Gamble's organic sales growth is likely the primary focus among investors following its fiscal fourth-quarter report, Morgan Stanley analysts say. Organic sales were flat in the quarter, solidly below the consensus estimate of 1.6% growth. Organic sales were hurt by retailer inventory cuts, as well as the timing of Easter and Amazon Prime Day, the analysts say. The metric was lower-than-expected in every segment besides Beauty, they say. The miss is likely what is pressuring the stock down 2% following the report, the analysts say.